BRKRBRUKER CORP

Nasdaq bruker.com


$ 64.81 $ -0.58 (-0.88 %)    

Wednesday, 21-Aug-2024 14:57:27 EDT
QQQ $ 482.68 $ 1.57 (0.33 %)
DIA $ 409.13 $ -0.11 (-0.03 %)
SPY $ 560.85 $ 0.92 (0.16 %)
TLT $ 98.97 $ 0.29 (0.29 %)
GLD $ 232.50 $ 0.84 (0.36 %)
$ 65.08
$ 65.39
$ 64.84 x 100
$ 65.11 x 134
$ 64.78 - $ 65.43
$ 53.68 - $ 94.79
1,096,950
na
9.63B
$ 0.98
$ 27.36
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-07-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-27-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-09-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 03-01-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-16-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-01-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-05-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-06-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-07-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-hold-on-bruker-lowers-price-target-to-72

TD Cowen analyst Max Masucci maintains Bruker (NASDAQ:BRKR) with a Hold and lowers the price target from $74 to $72.

 bruker-announced-a-minority-investment-in-novalix-a-preclinical-contract-research-organization-specializing-in-drug-discovery-services-financial-details-of-the-investment-were-not-disclosed

The minority investment aims to accelerate the growth and further expansion of NovAliX, particularly within Europe and the Unit...

 bruker-q2-2024-adj-eps-052-inline-sales-800700m-beat-796541m-estimate

Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. The company repo...

 citigroup-maintains-buy-on-bruker-lowers-price-target-to-80

Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Buy and lowers the price target from $95 to $80.

 goldman-sachs-maintains-sell-on-bruker-lowers-price-target-to-60

Goldman Sachs analyst Matthew Sykes maintains Bruker (NASDAQ:BRKR) with a Sell and lowers the price target from $72 to $60.

 cellens-is-collaborating-with-bruker-bioafm-a-business-unit-of-bruker-to-develop-the-worlds-first-clinical-diagnostic-tests-that-leverage-multi-parametric-single-cell-biophysical-markers-and-machine-learning

Based on cellular biophysical markers attained using Bruker's advanced atomic force microscopy, Cellens is developing its p...

 bruker-launches-neoflex-maldi-tof-system-for-spatial-biology-mass-spec-imaging-msi-applications-timstof-ultra-2-to-enable-new-research-paradigms-in-single-cell-and-subcellular-proteomics

At the 72nd ASMS meeting, Bruker Corporation (NASDAQ:BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF syst...

 why-bruker-brkr-shares-are-falling-during-thursdays-session

Bruker shares are trading lower by 6.6% during Thursday's session. The company announced a public offering of 6 million sha...

 reported-earlier-bruker-prices-public-offering-of-6m-shares-of-common-stock

Bruker intends to use the net proceeds from the offering to reduce indebtedness following its recent strategic acquisitions, in...

 bruker-announces-public-offering-of-6m-shares-of-common-stock

Bruker Corporation ("Bruker" or the "Company") (NASDAQ:BRKR) today announced the launch of an underwritten regi...

 stifel-maintains-hold-on-bruker-lowers-price-target-to-77

Stifel analyst Daniel Arias maintains Bruker (NASDAQ:BRKR) with a Hold and lowers the price target from $81 to $77.

 b-of-a-securities-maintains-buy-on-bruker-lowers-price-target-to-90

B of A Securities analyst Derik De Bruin maintains Bruker (NASDAQ:BRKR) with a Buy and lowers the price target from $95 to $90.

Core News & Articles

NanoString, now a Bruker business, will promptly seek an end to the injunction impacting sales of CosMx SMI products in Germany...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION